Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Shanghai International Convention Center

May 11, 2014 8:30 AM - May 11, 2014 5:30 PM

No. 2727, Riverside Avenue, Pudong, 200120 Shanghai, China

Workshop3: Early Clinical Development from First-in-Human (FIH) to Proof of Concept (POC)

Speakers

E. Dennis  Bashaw, PharmD

E. Dennis Bashaw, PharmD

Senior Science Advisor, Office of Clinical Pharmacology, FDA, United States

Bin  PENG, MD, PhD

Bin PENG, MD, PhD

, Novartis, China

Chao  Chen, PhD

Chao Chen, PhD

, GlaxoSmithKline R&D, UK, China

Rujia  Xie

Rujia Xie

Associate Director, Clinical Pharmacology & Pharmacometrics, Pfizer (China) Research and Development Co.,Ltd, China

Pei  HU

Pei HU

Director, Phase I Unit, Clinical Pharmacological Research Center, Peking Union Medical College, China

Hu Pei, MD, is Professor of Clinical Pharmacology and Director, Phase I Unit, Beijing Key Laboratory of Clinical PK/PD, Clinical Pharmacological Research Center, Peking Union Medical College Hospital. She has engaged in the teaching and research of clinical pharmacology, primarily in early clinical research and quantitative pharmacology of new drugs, for two decades. Professor Pei previously engaged in postdoctoral research at the Department of Medicinal Chemistry, University of Washington (US) through funding from the US National Institutes of Health Fogarty Fellowship, and has published more than 70 peer-reviewed articles. She earned her Doctorate in Medicine from Peking Union Medical College.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.